Consumables

WACKER Expands Collaboration with DKSH in Southeast Asia

Tuesday 06. November 2012 - The Munich-based WACKER Group is expanding collaboration with the Swiss market expansion services group DKSH in Southeast Asia. In addition to representing WACKER biotech products, DKSH will market pyrogenic silica and silicones for the cosmetic, food and pharmaceutical industries beginning in November.

WACKER transferred responsibility for marketing cyclodextrins, cystine and cysteine in Southeast Asia to DKSH in early October. Starting in November, the regional service portfolio of this market expansion services group will also include some of the chemical company’s other products. The specific products in question are pyrogenic silicas (sold under the HDK trademark) and BELSIL functionalized silicones, both of which are used as auxiliaries or additives in a variety of formulations in personal care, food and pharmaceutical products.
WACKER has noted a growing demand in Southeast Asia for high-quality cosmetic and pharmaceutical ingredients for years. Because pyrogenic silicas and silicones are highly versatile and physiologically well tolerated, many manufacturers have begun using them for formulating sophisticated personal care and pharmaceutical products. “The markets in Southeast Asia are experiencing dynamic growth and becoming more and more important to us,” stresses Dr. Jürgen Frisch, head of Distribution Management at WACKER. “Collaboration with DKSH now allows us to better serve potential customers in the region while continuing to develop our market position for pyrogenic silica and BELSIL products.”